SMYD2 promotes cervical cancer growth by stimulating cell proliferation

BACKGROUND: Cervical cancer is the most common gynecological malignancy with low terminal cure rate, and therefore new therapeutic targets are urgently needed to combat this disease. SMYD2, as an oncogene, is abnormal highly expressed in multiple types of tumors and further affects the occurrence an...

Full description

Saved in:
Bibliographic Details
Published in:Cell Biosci
Main Authors: Sun, Jun-Jie, Li, Hong-Lin, Ma, Hui, Shi, Yang, Yin, Li-Rong, Guo, Su-Jie
Format: Artigo
Language:Inglês
Published: BioMed Central 2019
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6749660/
https://ncbi.nlm.nih.gov/pubmed/31548876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13578-019-0340-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items